About
Rick joined PTV as a Managing Director in 2008. Rick currently sits on the boards of PTV portfolio companies Apollo Endosurgery, Corventis, Intersect ENT, and Tryton Medical, and he serves as Chairman of the Board for Cardiva Medical. Rick was also a Director at Cameron Health prior to its acquisition by Boston Scientific in June 2012 and Chairman of the Board for IDev Technologies prior to its acquisition by Abbott in August 2013. Prior to joining PTV, Rick was Company Group Chairman, Johnson & Johnson, and Worldwide Franchise Chairman, Cordis Corporation. Rick also served as President of Cordis Corporation and was previously Worldwide Franchise Vice President of Centocor, Inc., which merged with Johnson & Johnson in 1999. Rick was a key architect behind the launch of the world’s first drug-eluting stent, the CYPHER® Sirolimus-eluting Coronary Stent. This breakthrough innovation for the treatment of restenosis (reblockage) has been used to treat more than three million patients worldw
Position in the VCSift Database
- • 2 investors at Revival Healthcare Capital are tracked.
- • 1 investors hold the Chairman, Managing Director and Founder role in VCSift. Rick Anderson is one of them.
- • 1,334 investors are based in Austin, Texas, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Austin, US
Contact Information
Find more investors like Rick
Search Investors